Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Moderna (MRNA)

Tipranks - Tipranks - Wed Jan 7, 6:40AM CST

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neurocrine (NBIX – Research Report) and Moderna (MRNA – Research Report).

Claim 70% Off TipRanks Premium

Neurocrine (NBIX)

Truist Financial analyst Danielle Brill maintained a Buy rating on Neurocrine today. The company’s shares closed last Monday at $135.99.

According to TipRanks.com, Brill is a 5-star analyst with an average return of 14.3% and a 55.0% success rate. Brill covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Centessa Pharmaceuticals, and Dianthus Therapeutics. ;'>

Neurocrine has an analyst consensus of Strong Buy, with a price target consensus of $181.11, implying a 33.2% upside from current levels. In a report issued on December 22, William Blair also maintained a Buy rating on the stock.

See the top stocks recommended by analysts >>

Moderna (MRNA)

Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on Moderna today and set a price target of $24.00. The company’s shares closed last Monday at $32.17, close to its 52-week low of $29.25.

According to TipRanks.com, Stranahan is a 4-star analyst with an average return of 4.1% and a 52.3% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Recursion Pharmaceuticals, and Perspective Therapeutics. ;'>

Moderna has an analyst consensus of Hold, with a price target consensus of $29.79.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).